Sodium butyrate prevents cytokine‐induced β‐cell dysfunction through restoration of stromal interaction molecule 1 expression and activation of store‐operated calcium entry
The FASEB Journal · 2024
DOI: 10.1096/fj.202302501rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Chih-Chun Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Stromal Interaction Molecule 1, Butyric Acid, Calcium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, George and Frances Ball Foundation (GFBF), BLRD VA.
Abstract (Originalsprache)
Sodium butyrate (NaB) improves β‐cell function in preclinical models of diabetes; however, the mechanisms underlying these beneficial effects have not been fully elucidated. In this study, we investigated the impact of NaB on β‐cell function and calcium (Ca 2+ ) signaling using ex vivo and in vitro models of diabetes. Our results show that NaB significantly improved glucose‐stimulated insulin secretion in islets from human organ donors with type 2 diabetes and in cytokine‐treated INS‐1 β cells. Consistently, NaB improved glucose‐stimulated Ca 2+ oscillations in mouse islets treated with proinflammatory cytokines. Because the oscillatory phenotype of Ca 2+ in the β cell is governed by changes in endoplasmic reticulum (ER) Ca 2+ levels, we explored the relationship between NaB and store‐operated calcium entry (SOCE), a rescue mechanism that acts to refill ER Ca 2+ levels through STIM1‐mediated gating of plasmalemmal Orai channels. We found that NaB treatment preserved basal ER Ca 2+ levels and restored SOCE in IL‐1β‐treated INS‐1 cells. Furthermore, we linked these changes with the restoration of STIM1 levels in cytokine‐treated INS‐1 cells and mouse islets, and we found that NaB treatment was sufficient to prevent β‐cell death in response to IL‐1β treatment. Mechanistic experiments revealed that NaB mediated these beneficial effects in the β‐cell through histone deacetylase (HDAC) inhibition, iNOS suppression, and modulation of AKT‐GSK‐3 signaling. Taken together, these data support a model whereby NaB treatment promotes β‐cell function and Ca 2+ homeostasis under proinflammatory conditions through pleiotropic effects that are linked with maintenance of SOCE. These results also suggest a relationship between β‐cell SOCE and gut microbiome‐derived butyrate that may be relevant in the treatment and prevention of diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Physics, Indiana University Indianapolis, Indianpolis, Indiana, USA.
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana, USA.
ORCID-Profile: Chih-Chun Lee, Tatsuyoshi Kono, Farooq Syed, Staci A Weaver, Paul Sohn, Wenting Wu, Garrick Chang, Jing Liu, Marjan Slak Rupnik, Carmella Evans-Molina
Förderung
- NIDDK NIH HHS
- George and Frances Ball Foundation (GFBF)
- BLRD VA
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- VA | U.S. Department of Veterans Affairs
- Sigma Beta Sorority
- Ball Brothers Foundation (BBF)
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Lee, C. C., Kono, T., Syed, F., Weaver, S. A., Sohn, P., Wu, W., Chang, G., Liu, J., Slak Rupnik, M., & Evans-Molina, C. (2024). Sodium butyrate prevents cytokine‐induced β‐cell dysfunction through restoration of stromal interaction molecule 1 expression and activation of store‐operated calcium entry. The FASEB Journal. https://doi.org/10.1096/fj.202302501rr
Vancouver
Lee CC, Kono T, Syed F, Weaver SA, Sohn P, Wu W, et al. Sodium butyrate prevents cytokine‐induced β‐cell dysfunction through restoration of stromal interaction molecule 1 expression and activation of store‐operated calcium entry. The FASEB Journal. 2024. doi:10.1096/fj.202302501rr
BibTeX
@article{Lee2024,
author = {Lee, Chih-Chun and Kono, Tatsuyoshi and Syed, Farooq and Weaver, Staci A and Sohn, Paul and Wu, Wenting and Chang, Garrick and Liu, Jing and Slak Rupnik, Marjan and Evans-Molina, Carmella},
title = {Sodium butyrate prevents cytokine‐induced β‐cell dysfunction through restoration of stromal interaction molecule 1 expression and activation of store‐operated calcium entry},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202302501rr}
}
EUVIMED